AzTrials
AzTrials

Breast CancerBCSCNCT01831778

Breast Cancer Surveillance Consortium

An observational study of Breast Cancer, run by Kaiser Permanente at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Breast Cancer Surveillance Consortium (BCSC) database contains data from 1994-2009 on breast cancer screening, quality, and outcomes, and its main goal is to advance breast cancer research. This project is funded to maintain the BCSC database and share the data with investigators. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Breast Cancer
How many people
2,345,817 participants
Where
1 siteUnited States
Study dates
Jan 1994to Dec 2009
How long will I take part?
1 Year
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The BCSC pooled database includes data from seven BCSC registries, of which five are currently active. Information comes from a large study population that is ethnically, geographically, and socioeconomically diverse. The database currently includes 9 million mammograms from 2.3 million women interpreted by over 1400 radiologists at 400 facilities. There are 1.1 million digital mammograms; 660,000 ultrasounds; 180,000 benign and malignant biopsies; and records of over 155,000 deaths. Over 107,000 women have a breast cancer diagnosis, of which 83% are first diagnosed in 1994 or later. The data are collected in the course of routine, clinical care to accurately represent community practice.

Who may be able to join

  • 18 years of age

Who cannot join

  • none

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Group Health Cooperative

    Seattle, Washington, 98101

Other trials in United States

About this study

Official title: Breast Cancer Surveillance Consortium Data Resource

The Breast Cancer Surveillance Consortium (BCSC) database contains data from 1994-2009 on breast cancer screening, quality, and outcomes, and its main goal is to advance breast cancer research. This project is funded to maintain the BCSC database and share the data with investigators. Our objectives are to:

  • Maintain the BCSC pooled database using secure methods that protect the confidentiality of women, radiologists, facilities, and BCSC registries;
  • Encourage and facilitate sharing of BCSC research resources, and continue developing and implementing our communications plan to expand resource dissemination;
  • Provide statistical and scientific expertise to researchers, distribute customized limited datasets, and analyze BCSC data;
  • Develop and support a new web-based dynamic query tool and other electronic interfaces to efficiently share aggregated BCSC data with the public.
Read the detailed description

The BCSC is a collaboration of breast imaging registries formally established in 1994 with support from the National Cancer Institute (NCI). As the BCSC SCC, we coordinate standardized data collection, pool data from the registries, develop statistical methodology, conduct statistical analyses for research projects, and share data with within and beyond the consortium. The current BCSC database consists of data collected by five active mammography registries and two inactive registries:

  • Carolina Mammography Registry in North Carolina (CMR)
  • Group Health Registry in Seattle, Washington (GHC)
  • New Hampshire Mammography Network (NHMN)
  • San Francisco Mammography Registry (SFMR)
  • Vermont Breast Cancer Surveillance System (VBCSS)
  • New Mexico Mammography Project in Albuquerque (NMMP)
  • Colorado Mammography Advocacy Project (CMAP)

These registries have been actively collecting data since 1994 or 1996 (depending on registry) including patient risk factors, clinical history, breast-imaging procedures (screening and diagnostic), benign and malignant pathology results, cancer outcomes, vital status, radiologist characteristics, and facility information. Some registries have data going back to the 1970s; however, this information is mostly used to determine prior breast cancer diagnoses and mammography exposure. Most analysis limit data to 1994 forward.

Registry procedures:

BCSC data will be shared using 4 main approaches:

  1. Completed deidentified datasets and summary statistics made publicly available on the internet.
  2. A web-based data query tool for automatically creating user-specified completely deidentified data sets and summary statistics.
  3. Customized data sets created by the Statistical Coordinating Center (SCC) and delivered to investigators using secure methods, after BCSC steering committee approval of a research proposal.
  4. Statistical analyses performed by the SCC, after BCSC steering committee approval of a research proposal.

Quality factors:

The data used by the BCSC have been previously collected directly from each BCSC registry. The BCSC database has no personal identifiers such as names, phone numbers, addresses, or social security numbers and no one in the population will be contacted for additional data collection. The data set only contains HIPAA limited identifiers: dates, ages >89, and ZIP codes.

It is possible that new data will be collected under this contract as determined by the BCSC Steering Committee. This could include corrections to the current data, updates to existing data elements (e.g., additional radiology data, updated cancer and vital status outcomes), or new data elements (i.e., information about advanced imaging modalities, cancer biomarkers). New data will not contain personal identifiers. Individual-level data will never be shared unless rigorously examined and approved by the Steering Committee (which will include the principal investigators from each BCSC site) and the appropriate IRB safeguards are in place.

Our major objective for this contract is to maintain the current high standards of the BCSC database with no interruption in service to the scientific community. We will continue to be a resource to the research community, providing scientific and statistical expertise and conducting high-quality statistical analyses to advance breast cancer research. We will expand outreach and dissemination, so that more investigators are aware of this valuable resource and use it for their research. Our second objective is to develop new electronic interfaces and publicly available datasets that meet the highest possible standards for caBIG® compatibility. This will facilitate efficient sharing of BCSC data and expand potential for collaboration, increasing its value to the broader research community. Our ultimate aim is to facilitate research that improves breast cancer screening and reduces cancer burden and mortality.

Conditions
Breast Cancer
Keywords
mammography, screening
Medical subject headings
Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01831778
Study groupRoleWhat they receive
all womenwomen receiving mammography at one of 6 mammography registries across the country.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Breast cancer diagnosis

    Measured: 12 months

Secondary outcomes (1)
  1. mammography performance

    recall rate, sensitivity, specificity

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2013 (estimated)
  2. Study startJan 1994
  3. Primary completionDec 2009
  4. Study completionDec 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2,345,817 participants (actual)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT01831778
Sponsor's protocol ID
BCSC
Other IDs
261201100031C-0-0-1
Acronym
BCSC
Status last verified
Oct 2017
First submitted
11 Apr 2013
Last updated
13 Oct 2017
Results posted
No
Data monitoring committee
No

Publications

  • Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, Barlow WE, Geller BM, Kerlikowske K, Edwards BK, Lynch CF, Urban N, Chrvala CA, Key CR, Poplack SP, Worden JK, Kessler LG. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997 Oct;169(4):1001-8. doi: 10.2214/ajr.169.4.9308451. No abstract available.

    PubMed 9308451

Questions about this trial

What is this clinical trial studying?

An observational study of Breast Cancer, run by Kaiser Permanente at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Breast cancer diagnosis (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01831778, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in